Regulatory Divergence Becomes a Strategic Weapon for Shareholder Activists

The era of global regulatory convergence is rapidly giving way to a fragmented landscape, creating a vacuum that shareholder activists are now rushing to fill. For decades, multinational corporations operated under the assumption that major jurisdictions would eventually harmonize their standards for financial reporting, environmental disclosures, and corporate governance. However, as highlighted by a recent analysis from Akin Gump Strauss Hauer & Feld LLP, the widening gap between the United States, the European Union, and the United Kingdom has transformed from a mere compliance headache into a potent lever for institutional and activist investors.

At the heart of this shift is the concept of 'governance risk.' When a company operates across borders, it must navigate conflicting mandates—most notably the EU’s Corporate Sustainability Reporting Directive (CSRD) and the more cautious, litigation-sensitive approach of the U.S. Securities and Exchange Commission (SEC). Activists are now scrutinizing these discrepancies. If a company provides detailed climate impact data in its European filings but omits similar granularity in its U.S. disclosures to avoid domestic political or legal backlash, activists characterize this as a failure of transparency or a lack of coherent global strategy. This 'regulatory arbitrage' in reverse allows activists to argue that boards are failing to manage the long-term risks associated with disparate legal environments.

“

Securities and Exchange Commission (SEC).

Strategic friction is also manifesting in the realm of global M&A and antitrust enforcement. The divergence in how the Federal Trade Commission (FTC), the UK’s Competition and Markets Authority (CMA), and the European Commission evaluate market dominance has made cross-border deals significantly more precarious. Shareholder activists are using this uncertainty to oppose mergers or demand the divestiture of business units that face disproportionate regulatory burdens in specific regions. By framing regulatory divergence as a drag on valuation, activists can build a compelling case for 'simplification'—often a euphemism for breaking up multinational conglomerates into more localized, jurisdictionally focused entities.